Stay updated with breaking news from Precision Biosensor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the new market research report "Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular...
/PRNewswire/ -- According to the new market research report "Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular...
Yulchon LLC and Government Contractors Association Int’l with Korea SME’s and startups agency is hosting the Online Global Procurement Opportunities Conference.
Yulchon LLC and Government Contractors Association with Korea SME’s and startups agency (KOSME) hosts Online Global Procurement Opportunities Conference
Posted : 2020-12-23 16:57 By Anna J. Park Microbiome- focused biopharmaceutical firm Genome & Company made its first-day debut on the nation's heavy-tech KOSDAQ market Wednesday, transferring its listing from the KONEX market ― the bourse market for venture startups and small- and medium-sized enterprises ― where its stocks had been traded since December 2018. Since its listing at KONEX two years ago, Genome & Company grew to be the market's top company in terms of market cap, with about 741 billion won as of the end of November. With Wednesday's transfer listing to KOSDAQ, the biopharma...